CN103467260A - Preparation method of 4-difluoromethoxy-3-hydroxybenzaldehyde - Google Patents

Preparation method of 4-difluoromethoxy-3-hydroxybenzaldehyde Download PDF

Info

Publication number
CN103467260A
CN103467260A CN2012101888069A CN201210188806A CN103467260A CN 103467260 A CN103467260 A CN 103467260A CN 2012101888069 A CN2012101888069 A CN 2012101888069A CN 201210188806 A CN201210188806 A CN 201210188806A CN 103467260 A CN103467260 A CN 103467260A
Authority
CN
China
Prior art keywords
preparation
compound
reaction
binding agent
acid binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101888069A
Other languages
Chinese (zh)
Inventor
肖旭华
孙占莉
袁博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Pharmaceutical Industry
China State Institute of Pharmaceutical Industry
Original Assignee
Shanghai Institute of Pharmaceutical Industry
China State Institute of Pharmaceutical Industry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry filed Critical Shanghai Institute of Pharmaceutical Industry
Priority to CN2012101888069A priority Critical patent/CN103467260A/en
Publication of CN103467260A publication Critical patent/CN103467260A/en
Pending legal-status Critical Current

Links

Abstract

A disclosed preparation method of 4-difluoromethoxy-3-hydroxybenzaldehyde comprises the following steps: in an organic solvent, in the presence of a catalyst tetrabutylammonium bromide, under the effect of an acid binding agent, performing a nucleophilic substitution reaction on a compound 2 and difluorochloromethane, wherein the reaction temperature is 60-120 DEG C, and the organic solvent is one or more of isopropanol, DMF and 1, 4-dioxane. The preparation method is high in product yield and applicable to industrialized production.

Description

The preparation method of a kind of 3-hydroxyl-4-difluoro-methoxy phenyl aldehyde
Technical field
The present invention is specifically related to the preparation method of a kind of 3-hydroxyl-4-difluoro-methoxy phenyl aldehyde.
Background technology
3-hydroxyl-4-difluoro-methoxy phenyl aldehyde is the important intermediate for preparing the phosphodiesterase 4 inhibitors roflumilast.The synthetic method of 3-hydroxyl-4-difluoro-methoxy phenyl aldehyde normally makes with 0412 and fluorizating agent reaction.Can react with difluoromethyl because 0412 has two hydroxyls, therefore, in reactant, except the monosubstituted product of the 4-OH of needs, also have by product 3,4-difluoro-methoxy phenyl aldehyde (two replacement), generate.Due to disubstituted generation, make the yield of the monosubstituted product of 4-OH descend.
How to improve the mono-substituted productive rate of 4-OH, have many patents to report.As patent documentation US2008/15226, adopting chlorine difluoroacetic acid sodium is fluorizating agent, take sodium hydroxide as acid binding agent 120 ℃ of reacting by heating in DMF, reaction 2h, productive rate 44%.WO2004/94411, US2007/254913, EP2070913, be also that employing chlorine difluoroacetic acid sodium is fluorizating agent, the sodium hydroxide of take heats 55 ℃ as acid binding agent in DMF, reaction 16h, productive rate 24%.US2010/29728, WO2008/142542, WO2010/84402, be to take chlorodifluoromethane as fluorizating agent, salt of wormwood is acid binding agent, heats 75 ℃~85 ℃ in DMF with 0412, reaction 4.5h, productive rate 25%~30%.US5731477, WO2006/44528, Chauret Nathalie, Guay Daniel, Li Chun.etal.Bioorganic& Medicinal Chemistry Letters; Vol.12; Nb.16; (2002); P.2149-2152, Guay Daniel, Hamel Pierre, Blouin Marc.etl Bioorganic& Medicinal Chemistry Letters; Vol.12; Nb.11; (2002); P.1457-1462, Zheng Shilong, Kaur Gurpreet, etal.Journal of Medicinal Chemistry; Vol.51; Nb.24; (2008); P.7673-7688 the method for report is to take the chlorine methyl difluoroacetate as fluorizating agent, and the cesium carbonate of take is warmed up to 60 ℃~65 ℃ in DMF as acid binding agent, and productive rate is 20%~21%, and the main drawback of the method is that cost is high, and yield is low.It is catalyzer that WO2005/21515 adopts benzyltriethylammoinium chloride (TEBA), take chlorodifluoromethane as fluorizating agent, and in DMF, reaction prepares 3-hydroxyl-4-difluoro-methoxy phenyl aldehyde.The weak point of these methods is that reaction conversion ratio is low, and productive rate is low, has a large amount of 0412s to reclaim, the recovery complexity of 0412, and aftertreatment is loaded down with trivial details.
Summary of the invention
Technical problem to be solved by this invention is in the preparation method in order to overcome existing 3-hydroxyl-4-difluoro-methoxy phenyl aldehyde, reaction conversion ratio is low, products collection efficiency is low, the defects such as cost is high, and aftertreatment is loaded down with trivial details, and the preparation method of a kind of 3-hydroxyl-4-difluoro-methoxy phenyl aldehyde is provided.Preparation method's of the present invention products collection efficiency is higher, is suitable for suitability for industrialized production.
The invention provides the preparation method of a kind of 3-hydroxyl as shown in Equation 3-4-difluoro-methoxy phenyl aldehyde, it comprises the following step: in organic solvent, under the catalysis of normal-butyl bromination ammonium, under the effect of acid binding agent, compound 2 and chlorodifluoromethane are carried out to nucleophilic substitution reaction as follows, get final product; Temperature of reaction is 60~120 ℃; Described organic solvent is one or more in Virahol, DMF and Isosorbide-5-Nitrae-dioxane;
Figure BSA00000731528100021
In the present invention, described preparation method preferably comprises the following step: acid binding agent and solution A are mixed, pass into dichlorodifluoromethane, at 60~120 ℃ of temperature, carry out nucleophilic substitution reaction, get final product; Wherein, solution A is that compound 2 and normal-butyl bromination ammonium are dissolved in the solution formed in organic solvent.Better, acid binding agent wherein is in batches (as 2~5 times, preferably 3 times) join in reaction solution, before passing into dichlorodifluoromethane, with solution A, mix for the 1st time, the 2nd time later for to mix with reaction solution after starting to pass into dichlorodifluoromethane, and the timed interval at every turn added is preferably 1~2 hour (preferably 1.5 hours).Minute add for 3 times fashionablely, add-on is preferably: being 0.8~1.3 times of equivalent of compound 2 (preferably 1.1 times) for the first time, is 0.2~0.5 equivalent (preferably 0.3 equivalent) of compound 2 for the second time, is 0.3~0.4 equivalent of compound 2 for the third time.
In the present invention, described organic solvent is preferably Virahol.Organic solvent can be 5~30ml/g with the volume mass ratio of compound 2.
In the present invention, described acid binding agent can be one or more in sodium hydroxide, potassium hydroxide, sodium carbonate, salt of wormwood and cesium carbonate, and preferably sodium hydroxide, can adopt the aqueous sodium hydroxide solution of mass percent 30% to participate in reaction.The equivalence ratio of described compound 2 and acid binding agent be preferably 1: 1.5~1: 2 better be 1: 1.5~1: 1.7, further preferably 1: 1.6~1: 1.7.
In the present invention, described compound 2 is preferably 1 with the mol ratio of normal-butyl bromination ammonium: (0.5%~5%), better is 1: (0.5~1.5%) (as 1: 1%).
In the present invention, the temperature of reaction is preferably 60~90 ℃.The time of reaction can, by till detecting this reaction and no longer carrying out, be preferably 8~13 hours.
Without prejudice to the field on the basis of common sense, above-mentioned each optimum condition, but arbitrary combination obtains the preferred embodiments of the invention.
Agents useful for same of the present invention and raw material be commercially available obtaining all.
Positive progressive effect of the present invention is: preparation method's of the present invention products collection efficiency is higher, is suitable for suitability for industrialized production.
Embodiment
Mode below by embodiment further illustrates the present invention, but does not therefore limit the present invention among described scope of embodiments.The experimental technique of unreceipted actual conditions in the following example, according to ordinary method and condition, or select according to catalogue.
Embodiment 1:3, the preparation of 4-Dihydroxy benzaldehyde
Figure BSA00000731528100031
Thermometer is being housed, add vanillin food grade,1000.000000ine mesh (compound 1) in constant pressure funnel and churned mechanically 1000ml four-hole bottle (100.00g) and anhydrous methylene chloride (195ml), stirring at room is even, (0.70g), stirring at room is to the solid CL to add aluminum trichloride (anhydrous) (123.5g) and TEBA (triethyl benzyl ammonia chloride).Slowly evenly drip pyridine (170ml) at 0~5 ℃, slowly be warming up to backflow (46-48 ℃), after backflow 9h, temperature is down to below 10 ℃, regulate pH=2 (1000ml) with 20% hydrochloric acid, dichloromethane extraction (2 * 400ml) reclaims raw material, ethyl acetate for water (3 * 500ml) extraction.Merge organic phase, anhydrous sodium sulfate drying, remove solvent under reduced pressure, 40 ℃ of vacuum-dryings, obtain palm fibre white or yellow pressed powder 0412 (compound 2), productive rate 96.5%, fusing point: 152.5~153.1 ℃ (151~153 ℃ or 150~52 ℃ of bibliographical informations).MS (ESI +): [M+H]: 139.04, HPLC:98% can be directly used in next step reaction.
The preparation of embodiment 2:3-hydroxyl-4-difluoro-methoxy phenyl aldehyde
Figure BSA00000731528100041
Compound 2 (5.00g, 36.2mmol, 1.0eq) and normal-butyl bromination ammonium (0.117g, 0.362mmol, 1%eq) be dissolved in Virahol (60ml), stirring at room 20min, add 30% sodium hydroxide solution (1.59g, 39.82mmol, 1.1eq), stirring at room 30min, slowly be warming up to 65 ℃, start to pass into chlorodifluoromethane, temperature remains on 60~65 ℃, 1.5h after add 30% sodium hydroxide (0.43g, 10.86mmol, 0.3eq), continue reaction, add again 30% sodium hydroxide solution (0.43g after 1.5h, 10.86mmol, 0.3eq), continue reaction 5~6h, temperature drops to 15 ℃, add the water termination reaction.Filter, remove solid residue, filtrate is extracted with ethyl acetate, and merges organic phase, be washed to neutrality, anhydrous sodium sulfate drying, steaming desolventizes, silica gel column chromatography (sherwood oil: ethyl acetate 5: 1), obtain white solid powder (compound 3), productive rate 43.6%.MS(ESI +):M+H:189.0368。HPLC:98%。
The preparation of embodiment 3:3-hydroxyl-4-difluoro-methoxy phenyl aldehyde
Figure BSA00000731528100051
Compound 2 (5.00g, 36.2mmol, 1.0eq) and normal-butyl bromination ammonium (0.117g, 0.362mmol, 1%eq) be dissolved in Virahol (60ml), stirring at room 20min, add 30% sodium hydroxide solution (1.59g, 39.82mmol, 1.1eq), stirring at room 30min, slowly be warming up to 65 ℃, start to pass into chlorodifluoromethane, temperature remains on 70~75 ℃, 1.5h after add 30% sodium hydroxide (0.43g, 10.86mmol, 0.3eq), continue reaction, add again 30% sodium hydroxide solution (0.43g after 1.5h, 10.86mmol, 0.3eq), continue reaction 5~6h, temperature drops to 15 ℃, add the water termination reaction.Filter, remove solid residue, filtrate is extracted with ethyl acetate, and merges organic phase, be washed to neutrality, anhydrous sodium sulfate drying, steaming desolventizes, silica gel column chromatography (sherwood oil: ethyl acetate 5: 1), obtain white solid powder (compound 3), productive rate 51%.MS(ESI +):M+H:189.0368。HPLC:98%
The preparation of embodiment 4:3-hydroxyl-4-difluoro-methoxy phenyl aldehyde
Figure BSA00000731528100052
Compound 2 (5.00g, 36.2mmol, 1.0eq) and normal-butyl bromination ammonium (0.117g, 0.362mmol, 1%eq) be dissolved in Virahol (60ml), stirring at room 20min, add 30% sodium hydroxide solution (1.59g, 39.82mmol, 1.1eq), stirring at room 30min, slowly be warming up to 65 ℃, start to pass into chlorodifluoromethane, temperature remains on 120 ℃, 1.5h after add 30% sodium hydroxide (0.43g, 10.86mmol, 0.3eq), continue reaction, add again 30% sodium hydroxide solution (0.43g after 1.5h, 10.86mmol, 0.3eq), continue reaction 5~6h, temperature drops to 15 ℃, add the water termination reaction.Filter, remove solid residue, filtrate is extracted with ethyl acetate, and merges organic phase, be washed to neutrality, anhydrous sodium sulfate drying, steaming desolventizes, silica gel column chromatography (sherwood oil: ethyl acetate 5: 1), obtain white solid powder (compound 3), productive rate 47.3%.MS(ESI +):M+H:189.0368。HPLC:98%
The preparation of embodiment 5:3-hydroxyl-4-difluoro-methoxy phenyl aldehyde
Figure BSA00000731528100061
Compound 2 (13.8g, 0.1mol, 1.0eq) and normal-butyl bromination ammonium (0.322g, 1mmol, 1%eq) be dissolved in DMF (100ml), stirring at room 20min, add 30% sodium hydroxide solution (4.4g, 0.11mol, 1.1eq), stirring at room 30min, slowly be warming up to 65 ℃, start to pass into chlorodifluoromethane, temperature remains on 70~75 ℃, 1.5h after add 30% sodium hydroxide (1.2g, 0.03mol, 0.3eq), continue reaction, add again 30% sodium hydroxide solution (1.2g after 1.5h, 0.03mol, 0.3eq), continue reaction 5~6h, temperature drops to 15 ℃, add the water termination reaction.Filter, remove solid residue, filtrate is extracted with ethyl acetate, and merges organic phase, be washed to neutrality, anhydrous sodium sulfate drying, steaming desolventizes, silica gel column chromatography (sherwood oil: ethyl acetate 5: 1), obtain white solid powder (compound 3), productive rate 48.2%. 1H-NMR(CDCl 3,400MHz)δ6.1(br?s,IH),6.48-6.85(t,IH?OCHF 2),7.26(d,IH),7.44(d,IH),7.55(s,IH),9.91(s,IH)。MS(ESI +):M+H:189.0368。HPLC:98%。
The preparation of embodiment 6:3-hydroxyl-4-difluoro-methoxy phenyl aldehyde
Figure BSA00000731528100062
Compound 2 (5.00g, 36.2mmol, 1.0eq) and normal-butyl bromination ammonium (0.058g, 0.181mmol, 0.5%eq) be dissolved in Virahol (60ml), stirring at room 20min, add 30% sodium hydroxide solution (1.59g, 39.82mmol, 1.1eq), stirring at room 30min, slowly be warming up to 65 ℃, start to pass into chlorodifluoromethane, temperature remains on 70~75 ℃, 1.5h after add 30% sodium hydroxide (0.43g, 10.86mmol, 0.3eq), continue reaction, add again 30% sodium hydroxide solution (0.43g after 1.5h, 10.86mmol, 0.3eq), continue reaction 5~6h, temperature drops to 15 ℃, add the water termination reaction.Filter, remove solid residue, filtrate is extracted with ethyl acetate, and merges organic phase, be washed to neutrality, anhydrous sodium sulfate drying, steaming desolventizes, silica gel column chromatography (sherwood oil: ethyl acetate 5: 1), obtain white solid powder (compound 3), productive rate 47.6%. 1H-NMR(CDCl 3,400MHz)δ6.1(br?s,IH),6.48-6.85(t,IH?OCHF 2),7.26(d,IH),7.44(d,IH),7.55(s,IH),9.91(s,IH)。MS(ESI +):M+H:189.0368。HPLC:98%。
The preparation of embodiment 7:3-hydroxyl-4-difluoro-methoxy phenyl aldehyde
Figure BSA00000731528100071
Compound 2 (5.00g, 36.2mmol, 1.0eq) and normal-butyl bromination ammonium (0.585g, 1.81mmol, 5%eq) be dissolved in Virahol (60ml), stirring at room 20min, add 30% sodium hydroxide solution (1.59g, 39.82mmol, 1.1eq), stirring at room 30min, slowly be warming up to 65 ℃, start to pass into chlorodifluoromethane, temperature remains on 70~75 ℃, 1.5h after add 30% sodium hydroxide (0.43g, 10.86mmol, 0.3eq), continue reaction, add again 30% sodium hydroxide solution (0.43g after 1.5h, 10.86mmol, 0.3eq), continue reaction 5~6h, temperature drops to 15 ℃, add the water termination reaction.Filter, remove solid residue, filtrate is extracted with ethyl acetate, and merges organic phase, be washed to neutrality, anhydrous sodium sulfate drying, steaming desolventizes, silica gel column chromatography (sherwood oil: ethyl acetate 5: 1), obtain white solid powder (compound 3), productive rate 49%. 1H-NMR(CDCl 3,400MHz)δ6.1(br?s,IH),6.48-6.85(t,IHOCHF 2),7.26(d,IH),7.44(d,IH),7.55(s,IH),9.91(s,IH)。MS(ESI +):M+H:189.0368。HPLC:98%。
The preparation of embodiment 8:3-hydroxyl-4-difluoro-methoxy phenyl aldehyde
Figure BSA00000731528100072
Compound 2 (4.00g, 28.9mmol, 1.0eq) and normal-butyl bromination ammonium (0.448g, 1.39mmol, 5%eq) be dissolved in 1, in 4-dioxane (44.6ml), stirring at room 20min, temperature is raised to 65 ℃, add 30% sodium hydroxide solution (1.21g, 31.79mmol, 1.1eq), stirring at room 30min, slowly be warming up to 80 ℃, start to pass into chlorodifluoromethane, temperature remains on 80 ℃, 1.5h after add 30% sodium hydroxide (0.347g, 8.6mmol, 0.3eq), continue reaction, add again 30% sodium hydroxide solution (0.347g after 1.5h, 8.6mmol, 0.3eq), continue reaction 5~6h, temperature drops to 15 ℃, add the water termination reaction.Filter, remove solid residue, filtrate is extracted with ethyl acetate, and merges organic phase, be washed to neutrality, anhydrous sodium sulfate drying, steaming desolventizes, silica gel column chromatography (sherwood oil: ethyl acetate 5: 1), obtain white solid powder (compound 3), productive rate 47.3%. 1H-NMR(CDCl 3,400MHz)δ6.1(br?s,IH),6.48-6.85(t,IH?OCHF 2),7.26(d,IH),7.44(d,IH),7.55(s,IH),9.91(s,IH)。MS(ESI +):M+H:189.0368。HPLC:98%。
The preparation of embodiment 9:3-hydroxyl-4-difluoro-methoxy phenyl aldehyde
Compound 2 (13.8g, 0.1mol, 1.0eq) and normal-butyl bromination ammonium (0.161g, 0.5mmol, 0.5%eq) be dissolved in DMF (100ml), stirring at room 20min, add 30% sodium hydroxide solution (3.2g, 0.8mol, 0.8eq), stirring at room 30min, slowly be warming up to 65 ℃, start to pass into chlorodifluoromethane, temperature remains on 70~75 ℃, add 30% sodium hydroxide (2.0g after 2h, 0.05mol, 0.5eq), continue reaction, add again 30% sodium hydroxide solution (1.6g after 1h, 0.04mol, 0.4eq), continue reaction 5~6h, temperature drops to 15 ℃, add the water termination reaction.Filter, remove solid residue, filtrate is extracted with ethyl acetate, and merges organic phase, be washed to neutrality, anhydrous sodium sulfate drying, steaming desolventizes, silica gel column chromatography (sherwood oil: ethyl acetate 5: 1), obtain white solid powder (compound 3), productive rate 47.7%. 1H-NMR(CDCl 3,400MHz)δ6.1(br?s,IH),6.48-6.85(t,IHOCHF 2),7.26(d,IH),7.44(d,IH),7.55(s,IH),9.91(s,IH)。MS(ESI +):M+H:189.0368。HPLC:98%.。
The preparation of embodiment 10:3-hydroxyl-4-difluoro-methoxy phenyl aldehyde
Compound 2 (5.00g, 36.2mmol, 1.0eq) and normal-butyl bromination ammonium (0.585g, 1.81mmol, 5%eq) be dissolved in Virahol (60ml), stirring at room 20min, add 30% sodium hydroxide solution (1.88g, 47.06mmol, 1.3eq), stirring at room 30min, slowly be warming up to 65 ℃, start to pass into chlorodifluoromethane, temperature remains on 120 ℃, add 30% sodium hydroxide (0.43g after 1h, 10.86mmol, 0.3eq), continue reaction, add again 30% sodium hydroxide solution (0.58g after 2h, 14.33mmol, 0.4eq), continue reaction 5~6h, temperature drops to 15 ℃, add the water termination reaction.Filter, remove solid residue, filtrate is extracted with ethyl acetate, and merges organic phase, be washed to neutrality, anhydrous sodium sulfate drying, steaming desolventizes, silica gel column chromatography (sherwood oil: ethyl acetate 5: 1), obtain white solid powder (compound 3), productive rate 48.3%.MS(ESI +):M+H:189.0368。HPLC:98%?。

Claims (10)

1. the preparation method of 3-hydroxyl as shown in Equation 3-4-difluoro-methoxy phenyl aldehyde, it is characterized in that comprising the following step: in organic solvent, under the catalysis of normal-butyl bromination ammonium, under the effect of acid binding agent, compound 2 and chlorodifluoromethane are carried out to nucleophilic substitution reaction as follows, get final product; Temperature of reaction is 60~120 ℃; Described organic solvent is one or more in Virahol, DMF and Isosorbide-5-Nitrae-dioxane;
Figure FSA00000731528000011
2. preparation method as claimed in claim 1, it is characterized in that: described preparation method comprises the following step: acid binding agent and solution A are mixed, pass into dichlorodifluoromethane, at 60~120 ℃ of temperature, carry out nucleophilic substitution reaction, get final product; Wherein, solution A is that compound 2 and normal-butyl bromination ammonium are dissolved in the solution formed in organic solvent.
3. preparation method as claimed in claim 2, it is characterized in that: acid binding agent joins in reaction solution in batches, before passing into dichlorodifluoromethane, with solution A, mix for the 1st time, the 2nd time later for to mix with reaction solution after starting to pass into dichlorodifluoromethane, and the timed interval at every turn added is 1~2 hour.
4. preparation method as claimed in claim 3, it is characterized in that: acid binding agent divides 3 times to add fashionable, add-on is: being 0.8~1.3 times of equivalent of compound 2 for the first time, is 0.2~0.5 equivalent of compound 2 for the second time, is 0.3~0.4 equivalent of compound 2 for the third time.
5. preparation method as claimed in claim 4 is characterized in that: acid binding agent divides and adds for 3 times fashionablely, and add-on is: being 1.1 times of equivalents of compound 2 for the first time, is 0.3 times of equivalent of compound 2 for the second time.
6. preparation method as described as claim 1~5 any one, it is characterized in that: described acid binding agent is one or more in sodium hydroxide, potassium hydroxide, sodium carbonate, salt of wormwood and cesium carbonate.
7. preparation method as described as claim 1~5 any one is characterized in that: described compound 2 is 1: 1.5~1: 2 with the equivalence ratio of acid binding agent.
8. preparation method as described as claim 1~5 any one is characterized in that: described compound 2 is 1 with the mol ratio of normal-butyl bromination ammonium: (0.5%~5%).
9. preparation method as claimed in claim 8 is characterized in that: described compound 2 is 1 with the mol ratio of normal-butyl bromination ammonium: (0.5~1.5%).
10. preparation method as described as claim 1~5 any one, it is characterized in that: the temperature of reaction is 60~90 ℃.
CN2012101888069A 2012-06-08 2012-06-08 Preparation method of 4-difluoromethoxy-3-hydroxybenzaldehyde Pending CN103467260A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101888069A CN103467260A (en) 2012-06-08 2012-06-08 Preparation method of 4-difluoromethoxy-3-hydroxybenzaldehyde

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101888069A CN103467260A (en) 2012-06-08 2012-06-08 Preparation method of 4-difluoromethoxy-3-hydroxybenzaldehyde

Publications (1)

Publication Number Publication Date
CN103467260A true CN103467260A (en) 2013-12-25

Family

ID=49792342

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101888069A Pending CN103467260A (en) 2012-06-08 2012-06-08 Preparation method of 4-difluoromethoxy-3-hydroxybenzaldehyde

Country Status (1)

Country Link
CN (1) CN103467260A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106379644A (en) * 2016-11-15 2017-02-08 苏州亨达尔工业材料有限公司 Shockproof and anti-impact hollow board

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005021515A2 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005021515A2 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
钟永刚等: "罗氟司特的合成", 《中国医药工业杂志》, vol. 42, no. 12, 31 December 2011 (2011-12-31), pages 884 - 886 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106379644A (en) * 2016-11-15 2017-02-08 苏州亨达尔工业材料有限公司 Shockproof and anti-impact hollow board

Similar Documents

Publication Publication Date Title
CN101812095B (en) Preparation method of sucralose
CN104130258B (en) The method for transformation of a kind of dimer
CN102531856B (en) Method for synthesizing asymmetric diaryl ether derivative
CN106365986B (en) Compound and preparation method thereof and the purposes in synthesis Bu Waxitan
CN103483324B (en) The new preparation process of lapatinibditosylate
CN103242303B (en) Afatinib preparation method
CN101402555B (en) Method of preparing (Z)-3'-hydroxyl-3,4,4',5-tetramethoxy toluylene
CN104045602A (en) Improved method for preparing tetrazole for valsartan
CN103420902A (en) Preparation method of 2-chloro-4-iodo-5-methylpyridine
CN103539748A (en) Method for preparing 5-(3,6-dihydro-2,6-dioxo-4-trifluoromethyl-1(2h)-pyrimidinyl)phenylthiol compounds
CN103467260A (en) Preparation method of 4-difluoromethoxy-3-hydroxybenzaldehyde
CN103772278A (en) Important tetrahydroisoquinoline derivative midbody and synthesis method thereof
CN102757390B (en) Method for preparing 2-methoxy-4-diazanyl-5-fluoropyrimidine
CN105968103B (en) The synthetic method of anti-tumor drug Afatinib
CN101402607A (en) Synthesis of 1-isobutyl-2-methyl imidazole
CN104557744A (en) Preparation method of triazoie compound
CN105367499A (en) Preparation method of 2-ethyl-4-methylimidazole
CN104356056B (en) The preparation method of pyrrole Lun Panai intermediate
CN106588779A (en) Method for synthesizing dexmedetomidine hydrochloride intermediate
CN102659520B (en) Synthetic method of 2,3,5,6-tetrafluorobenzyl alcohol
CN106588765A (en) Method for hydroxylation of nitrogen oxide C2-position
CN102627571B (en) Preparation and synthesis method for chiral ammonium salt
CN104230723A (en) Synthesis method of toremifene
CN100546973C (en) The preparation method of 3-(N-methyl-N-penta amino) propionic salt hydrochlorate
CN103113297B (en) 8-aryl-1-naphthylamide compound and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20131225